These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1076 related items for PubMed ID: 8203723

  • 1. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM.
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [Abstract] [Full Text] [Related]

  • 2. Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier.
    Lebens M, Holmgren J.
    Dev Biol Stand; 1994; 82():215-27. PubMed ID: 7958476
    [Abstract] [Full Text] [Related]

  • 3. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S.
    Immunol Lett; 2005 Mar 15; 97(2):181-8. PubMed ID: 15752556
    [Abstract] [Full Text] [Related]

  • 4. [Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].
    Carrada Bravo T.
    Rev Alerg; 1993 Mar 15; 40(4):91-4. PubMed ID: 8143024
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
    Lycke N, Holmgren J.
    Immunology; 1986 Oct 15; 59(2):301-8. PubMed ID: 3021614
    [Abstract] [Full Text] [Related]

  • 9. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP, Lamm ME, Nedrud JG.
    J Immunol; 1988 Sep 01; 141(5):1495-501. PubMed ID: 2842395
    [Abstract] [Full Text] [Related]

  • 10. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ, Bianchi AT, Dol M, Pals JW, Stok W, Bokhout BA.
    Immunology; 1991 Jan 01; 72(1):89-93. PubMed ID: 1705237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
    Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T.
    Infect Immun; 2005 Sep 01; 73(9):5654-65. PubMed ID: 16113283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T, Yuki Y, Katakai Y, Shibata H, Tokuhara D, Mejima M, Kurokawa S, Takahashi Y, Nakanishi U, Ono F, Mimuro H, Sasakawa C, Takaiwa F, Terao K, Kiyono H.
    J Immunol; 2009 Nov 15; 183(10):6538-44. PubMed ID: 19880451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y, Kiyono H.
    Rev Med Virol; 2003 Nov 15; 13(5):293-310. PubMed ID: 12931340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.